Tag: growth stock
-
That was quick: Valeo Pharma (VPH.C) gets Health Canada nod for immune system booster
“There is a strong scientific and medical rationale for the use of Hesperco capsules to support the immune system,” stated Pierre Laurin, CEO of Ingenew, who added that it could “potentially fight off symptoms associated with coronaviruses.”
-
Nexus Gold (NXS.V) hits 13.25 grams/tonne over 2.75 meters at McKenzie Gold Project in Ontario
“Of the first six holes drilled (784 total meters), six returned elevated gold assays,” reported Nexus, “while the last three holes MK2020-004, 005, and 006, all contained zones reporting visible gold”.
-
Valeo Pharma Inc. (VPH.C) – THE undervalued biotech play
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38% returns on your investment. Better yet, if you had bought Valeo’s stock a month ago, you would have been up close to 184%, which, y’know, is…
-
Nexus Gold (NXS.V) in up-trend as USD weakens
In 2020, the U.S gov. has borrowed another $7 trillion, the U.S. dollar has weakened further, the flight to gold is now a stampede and many gold juniors have experienced sharp gains in share price.
-
Perimeter Medical Imaging AI (PINK.V): They’re not curing cancer here, but they’ll help dig it out..
For the last eight months, the Covid-19 virus has been the center of attention in the media, the markets, and the medical field. Collectively, countries and government agencies, and academia, and pharmaceutical companies, have poured hundreds of millions into efforts combating the plague that has left so many countries and populations struggling, but despite the…
-
Nexus Gold (NXS.V) doubles down on McKenzie drill program
This $15 million company owns 11 projects on two continents.
-
Plus Products (PLUS.C) just parachuted right into my world
Heimark has a track record of rigorous market research prior to launching products. This research-based approach has reaped dividends in market penetration and revenue growth.
-
Nexus Gold (NXS.V) samples 10.5 g/t gold in Burkina Faso
For a company with a modest market cap ($9.5 million) Nexus has a good track record of advancing multiple projects simultaneously on two continents (North America and Africa).
-
Plus Products (PLUS.C): good deeds, good products, good numbers
“This will be the third year we have had the opportunity to partner with a local organization during pride month,” stated Mr. Heimark. “Last year we sold over 60,000 units and are looking forward to giving that record a run for its money this year.”
-
Hemptown USA CEO Eric Gripentrog gives a pre-IPO update
We are currently primarily focused on wholesale, selling bulk products. Quickly, we will be pivoting to the $16 billion dollar industry which breaks out between nutraceuticals, beauty aids, food and beverages.